Content about multiple sclerosis

March 3, 2011
Merck receives CRL for MS treatment

The Food and Drug Administration declined to approve a Merck KGaA drug designed to treat relapsing-remitting multiple sclerosis.

January 11, 2011
Bayer: Betaseron not affected by prep pads recall

Bayer HealthCare Pharmaceuticals sought to reassure healthcare professionals and their patients that a recall of alcohol prep pads distributed with its multiple sclerosis drug did not affect the drug itself.

September 30, 2010
Teva unveils mid-stage clinical trial results for MS drug

Teva Pharmaceutical Industries and Active Biotech announced promising results from a mid-stage trial of laquinimod,...

September 21, 2010
FDA approves multiple sclerosis drug Gilenya

The Food and Drug Administration has approved a drug for reducing relapses in patients with...

September 9, 2010
Generic versions of Copaxone hit roadblock

Efforts by two generic drug makers to market a generic version of a drug for...

July 13, 2010
Datamonitor: Oral drugs set to dominate MS market by 2014

The market for multiple sclerosis drugs, long dominated by biologics and injectables, soon could see...

June 14, 2010
Genzyme's Campath gets fast-track designation from FDA

The Food and Drug Administration has agreed to speed up the review of a Genzyme...

June 13, 2010
FDA advisory committee gives nod to investigational MS drug

An advisory committee of the Food and Drug Administration unanimously recommended approval for an investigational...

June 8, 2010
Bayer HealthCare: Betaferon's safety record proven in follow-up trial

German drug maker Bayer HealthCare said a 16-year follow-up to a clinical trial of one...

June 2, 2010
Bayer launches iPhone app for Betaseron patients

German drug maker Bayer HealthCare Pharmaceuticals has created an iPhone application that it called the...

May 23, 2010
Biogen Idec, Abbott enroll patients in late-stage trial for MS drug

Swiss biotech company Biogen Idec and U.S. drug maker Abbott have begun enrolling patients in...

March 25, 2010
New clinical trial will compare MS drugs

Swiss drug maker Biogen Idec and Irish drug maker Elan Corp. have started enrolling patients...

January 20, 2010
Clinical trial finds Novartis drug reduces progression of MS

An investigational drug for treating multiple sclerosis reduced progression of disability by more than 30%,...

January 19, 2010
JDRF, Axxam, Fast Forward to develop diabetes, MS treatments

A group of companies and organizations plan to collaborate to develop new treatments for multiple...

August 20, 2009
Teva launches ‘Patient First’ project

Most consumers may not know a lot about biosimilar equivalence, immunogenicity or what “monoclonal antibody”...

© 2013 Drug Store News. All Rights Reserved.